Utah Operating Income from 2010 to 2026

UTMD Stock

USD 64.10 0.37 0.58%

Utah Medical's Operating Income is increasing over the years with slightly volatile fluctuation. Overall, Operating Income is expected to go to about 12.6 M this year. Operating Income is earnings before interest and taxes (EBIT), representing the amount of profit Utah Medical Products generates from its operations. View All Fundamentals

Operating Income

First Reported

1987-03-31

Previous Quarter

2.6 M

Current Value

2.4 M

Quarterly Volatility

1.4 M

Black Monday

Oil Shock

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Interest Hikes

Check Utah Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Utah Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.5 M, Interest Expense of 675.3 K or Total Revenue of 37 M, as well as many indicators such as Price To Sales Ratio of 3.48, Dividend Yield of 0.0242 or PTB Ratio of 1.48. Utah financial statements analysis is a perfect complement when working with Utah Medical Valuation or Volatility modules.

Build AI portfolio with Utah Stock

Check out the analysis of Utah Medical Correlation against competitors.

Analyzing Utah Medical's Operating Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Operating Income has evolved provides context for assessing Utah Medical's current valuation and future prospects.

Latest Utah Medical's Operating Income Growth Pattern

Below is the plot of the Operating Income of Utah Medical Products over the last few years. Operating Income is the amount of profit realized from Utah Medical Products operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Utah Medical Products is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. Utah Medical's Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Utah Medical's overall financial position and show how it may be relating to other accounts over time.

Operating Income

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Operating Income

Timeline

Utah Operating Income Regression Statistics

	Arithmetic Mean	14,863,620
	Geometric Mean	12,945,451
	Coefficient Of Variation	29.98
	Mean Deviation	2,986,683
	Median	15,651,000
	Standard Deviation	4,456,443
	Sample Variance	19.9T
	Range	19.1M
	R-Value	0.31
	Mean Square Error	19.2T
	R-Squared	0.09
	Significance	0.23
	Slope	269,194
	Total Sum of Squares	317.8T

Utah Operating Income History

	2026	12.6 M
	2025	11.4 M
	2024	13.6 M
	2023	16.8 M
	2022	19.8 M
	2021	18.9 M
	2020	13.7 M

Other Fundumenentals of Utah Medical Products

Non Operating Income Net Other

Utah Medical Operating Income component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Intangible Assets	Accounts Payable	Short Term Debt	Common Stock	Property Plant Equipment	Short Term Investments	Good Will	Current Deferred Revenue	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.82	-0.69	0.75	0.55	-0.12	0.71	-0.09	0.01	-0.32	-0.72	0.43	0.6	0.55	-0.3	0.72	-0.7	-0.32	0.03	0.11	0.67	0.65	-0.14
Total Stockholder Equity	0.82		-0.93	0.99	0.47	-0.48	0.95	-0.42	-0.17	-0.58	-0.72	0.54	0.84	0.33	-0.44	0.8	-0.69	-0.49	-0.09	-0.4	0.86	0.79	-0.56
Net Debt	-0.69	-0.93		-0.94	-0.21	0.69	-0.98	0.7	0.2	0.73	0.47	-0.64	-0.84	-0.01	0.45	-0.78	0.57	0.6	0.1	0.42	-0.91	-0.89	0.62
Retained Earnings	0.75	0.99	-0.94		0.43	-0.52	0.96	-0.47	-0.16	-0.59	-0.72	0.57	0.85	0.29	-0.41	0.78	-0.64	-0.53	-0.12	-0.51	0.87	0.8	-0.65
Net Receivables	0.55	0.47	-0.21	0.43		0.28	0.31	0.35	0.16	0.06	-0.65	-0.05	0.35	0.62	0.01	0.23	-0.32	-0.02	0.03	-0.03	0.21	0.14	-0.02
Total Liab	-0.12	-0.48	0.69	-0.52	0.28		-0.57	0.81	0.24	0.88	-0.12	-0.5	-0.55	0.51	0.6	-0.55	0.39	0.46	0.27	0.34	-0.56	-0.51	0.45
Total Current Assets	0.71	0.95	-0.98	0.96	0.31	-0.57		-0.63	-0.2	-0.62	-0.57	0.59	0.86	0.11	-0.35	0.74	-0.52	-0.58	-0.03	-0.48	0.93	0.91	-0.67
Intangible Assets	-0.09	-0.42	0.7	-0.47	0.35	0.81	-0.63		0.27	0.74	-0.15	-0.51	-0.49	0.59	0.38	-0.45	0.08	0.57	0.18	0.4	-0.61	-0.66	0.55
Accounts Payable	0.01	-0.17	0.2	-0.16	0.16	0.24	-0.2	0.27		0.16	0.12	0.14	-0.13	-0.04	0.14	-0.21	0.1	-0.16	0.08	0.2	-0.15	-0.19	0.31
Short Term Debt	-0.32	-0.58	0.73	-0.59	0.06	0.88	-0.62	0.74	0.16		0.02	-0.64	-0.53	0.38	0.58	-0.62	0.45	0.63	0.37	0.2	-0.52	-0.46	0.3
Common Stock	-0.72	-0.72	0.47	-0.72	-0.65	-0.12	-0.57	-0.15	0.12	0.02		-0.16	-0.41	-0.85	0.16	-0.58	0.61	0.08	0.14	0.32	-0.44	-0.41	0.42
Property Plant Equipment	0.43	0.54	-0.64	0.57	-0.05	-0.5	0.59	-0.51	0.14	-0.64	-0.16		0.6	-0.2	-0.24	0.41	-0.26	-0.8	0.01	-0.21	0.59	0.5	-0.35
Short Term Investments	0.6	0.84	-0.84	0.85	0.35	-0.55	0.86	-0.49	-0.13	-0.53	-0.41	0.6		0.01	-0.24	0.53	-0.34	-0.6	0.18	-0.46	0.92	0.81	-0.63
Good Will	0.55	0.33	-0.01	0.29	0.62	0.51	0.11	0.59	-0.04	0.38	-0.85	-0.2	0.01		-0.03	0.32	-0.5	0.36	-0.06	0.01	0.02	0.02	-0.02
Current Deferred Revenue	-0.3	-0.44	0.45	-0.41	0.01	0.6	-0.35	0.38	0.14	0.58	0.16	-0.24	-0.24	-0.03		-0.78	0.74	-0.02	0.46	0.04	-0.21	-0.16	0.07
Net Tangible Assets	0.72	0.8	-0.78	0.78	0.23	-0.55	0.74	-0.45	-0.21	-0.62	-0.58	0.41	0.53	0.32	-0.78		-0.88	-0.18	-0.37	-0.16	0.6	0.61	-0.35
Long Term Debt Total	-0.7	-0.69	0.57	-0.64	-0.32	0.39	-0.52	0.08	0.1	0.45	0.61	-0.26	-0.34	-0.5	0.74	-0.88		-0.02	0.34	-0.01	-0.36	-0.33	0.11
Capital Surpluse	-0.32	-0.49	0.6	-0.53	-0.02	0.46	-0.58	0.57	-0.16	0.63	0.08	-0.8	-0.6	0.36	-0.02	-0.18	-0.02		-0.04	0.23	-0.59	-0.51	0.35
Deferred Long Term Liab	0.03	-0.09	0.1	-0.12	0.03	0.27	-0.03	0.18	0.08	0.37	0.14	0.01	0.18	-0.06	0.46	-0.37	0.34	-0.04		0.08	0.17	0.15	0.01
Short Long Term Debt	0.11	-0.4	0.42	-0.51	-0.03	0.34	-0.48	0.4	0.2	0.2	0.32	-0.21	-0.46	0.01	0.04	-0.16	-0.01	0.23	0.08		-0.45	-0.4	0.89
Net Invested Capital	0.67	0.86	-0.91	0.87	0.21	-0.56	0.93	-0.61	-0.15	-0.52	-0.44	0.59	0.92	0.02	-0.21	0.6	-0.36	-0.59	0.17	-0.45		0.97	-0.69
Net Working Capital	0.65	0.79	-0.89	0.8	0.14	-0.51	0.91	-0.66	-0.19	-0.46	-0.41	0.5	0.81	0.02	-0.16	0.61	-0.33	-0.51	0.15	-0.4	0.97		-0.68
Capital Stock	-0.14	-0.56	0.62	-0.65	-0.02	0.45	-0.67	0.55	0.31	0.3	0.42	-0.35	-0.63	-0.02	0.07	-0.35	0.11	0.35	0.01	0.89	-0.69	-0.68

Click cells to compare fundamentals

About Utah Medical Financial Statements

Utah Medical stakeholders use historical fundamental indicators, such as Utah Medical's Operating Income, to determine how well the company is positioned to perform in the future. Although Utah Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Utah Medical's assets and liabilities are reflected in the revenues and expenses on Utah Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Utah Medical Products. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Operating Income	11.4 M	12.6 M
Non Operating Income Net Other	239.2 K	251.2 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

FSLY	Fastly Class A
MOB	Mobilicom Limited American
CMG	Chipotle Mexican Grill

When determining whether Utah Medical Products is a strong investment it is important to analyze Utah Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Utah Medical's future performance. For an informed investment choice regarding Utah Stock, refer to the following important reports:

How To Invest In Utah

Details

Is Utah Stock a good investment?

Details

What is Utah Medical's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out the analysis of Utah Medical Correlation against competitors.

You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Will Health Care Equipment & Supplies sector continue expanding? Could Utah diversify its offerings? Factors like these will boost the valuation of Utah Medical. If investors know Utah will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Utah Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.

Quarterly Earnings Growth

(0.06)

Dividend Share

1.225

Earnings Share

3.51

Revenue Per Share

11.889

Quarterly Revenue Growth

(0.01)

Utah Medical Products's market price often diverges from its book value, the accounting figure shown on Utah's balance sheet. Smart investors calculate Utah Medical's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Utah Medical's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.

Please note, there is a significant difference between Utah Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Utah Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Utah Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Utah Operating Income from 2010 to 2026

Latest Utah Medical's Operating Income Growth Pattern

Utah Operating Income Regression Statistics

Utah Operating Income History

Other Fundumenentals of Utah Medical Products

Utah Medical Operating Income component correlations

About Utah Medical Financial Statements

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY